Experimental group:Anti-SARS-CoV-2 virus inactivated plasma

2 trials

Sponsors

Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital), Renmin Hospital of Wuhan University

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Unknown Phase

A randomized, double-blind, parallel-controlled, trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia patients (COVID-19)

Active, not recruitingChiCTR2000030010

Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)Novel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-19Updated: 2020-02-25

A randomized, double-blind, parallel-controlled trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia (COVID-19)

Active, not recruitingChiCTR2000030929

Renmin Hospital of Wuhan UniversityNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-03-17Updated: 2020-03-23